LOADING
Comparing Merck & Company (MRK) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | KO |
|---|---|---|
| Price | $113.45 | $80.26 |
| Change Today | +0.96% | +0.29% |
| Market Cap | $280.2B | $347.9B |
| P/E Ratio | 32.0 | 25.4 |
| Forward P/E | 22.0 | 24.1 |
| PEG Ratio | 5.18 | 4.01 |
| EPS | $3.55 | $3.18 |
| Revenue Growth (YoY) | 4.9% | 12.1% |
| Profit Margin | 13.6% | 27.8% |
| Return on Equity | 18.9% | 43.4% |
| Dividend Yield | 2.92% | 2.57% |
| Beta | 0.20 | 0.36 |
| 52-Week High | $124.22 | $81.44 |
| 52-Week Low | $70.74 | $64.45 |
| Volume | 8.1M | 12.4M |
Coca-Cola Company is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.